Literature DB >> 17978302

Myocardial infarction induced by appetite suppressants in Malaysia.

Shah M Azarisman, Yahya A Magdi, Saidin Noorfaizan, Maskon Oteh.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17978302     DOI： 10.1056/NEJMc070990

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  6 in total

1.  Case series on a diversity of illicit weight-reducing agents: from the well known to the unexpected.

Authors:  Magdalene H Y Tang; Sammy P L Chen; Sau W Ng; Albert Y W Chan; Tony W L Mak
Journal:  Br J Clin Pharmacol       Date:  2011-02       Impact factor: 4.335

2.  Ventricular fibrillation coinciding with phentermine initiation.

Authors:  Patrick Tobbia; Leslie A Norris; Lawrence D Klima
Journal:  BMJ Case Rep       Date:  2012-10-12

Review 3.  Sibutramine on cardiovascular outcome.

Authors:  André J Scheen
Journal:  Diabetes Care       Date:  2011-05       Impact factor: 19.112

4.  Vasospastic myocardial infarction caused by a slimming agent-do not forget non-prescription drugs.

Authors:  Mohammed Omer Anwar; Neil Bodagh; Mohammed Husnain Iqbal; Adam Timmis
Journal:  Oxf Med Case Reports       Date:  2017-04-03

Review 5.  Clinical Considerations Regarding the Use of Obesity Pharmacotherapy in Adolescents with Obesity.

Authors:  Gitanjali Srivastava; Claudia K Fox; Aaron S Kelly; Ania M Jastreboff; Allen F Browne; Nancy T Browne; Janey S A Pratt; Christopher Bolling; Marc P Michalsky; Stephen Cook; Carine M Lenders; Caroline M Apovian
Journal:  Obesity (Silver Spring)       Date:  2019-02       Impact factor: 5.002

6.  Myocardial infarction caused by pharmacological substances - case description and literature review.

Authors:  Tomasz Kameczura; Leszek Bryniarski; Sławomir Surowiec; Maryla Kocowska; Kalina Kawecka-Jaszcz; Danuta Czarnecka
Journal:  Postepy Kardiol Interwencyjnej       Date:  2013-09-16       Impact factor: 1.426
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.